New York Life Investment Management LLC Coherus Bio Sciences, Inc. Transaction History

New York Life Investment Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	BUY	$2.02 - $3.14 $212,259 - $329,948	105,079 Added 210.34%	155,036 $370,000
Q4 2023 Feb 05, 2024	SELL	$1.59 - $3.85 $3,332 - $8,069	-2,096 Reduced 4.03%	49,957 $166,000
Q3 2023 Nov 07, 2023	SELL	$3.74 - $5.45 $30,671 - $44,695	-8,201 Reduced 13.61%	52,053 $194,000
Q2 2023 Aug 04, 2023	SELL	$3.79 - $8.3 $47,943 - $104,995	-12,650 Reduced 17.35%	60,254 $257,000
Q1 2023 May 08, 2023	BUY	$5.89 - $10.52 $429,404 - $766,950	72,904 New	72,904 $498,000

143

82.7M

79.1K

100K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $81.6M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of New York Life Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on New York Life Investment Management LLC with notifications on news.